What is the recommended dosage of bilastine (antihistamine) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bilastine Pediatric Dosage

The recommended dose of bilastine for children aged 2 to <12 years is 10 mg once daily, administered as an orodispersible tablet, while adolescents ≥12 years should receive the adult dose of 20 mg once daily. 1, 2, 3

Age-Specific Dosing

Children 2 to <12 Years

  • Administer 10 mg once daily using orodispersible tablets 1, 2, 3
  • This dose achieves comparable systemic exposure (AUC and Cmax) to the therapeutic 20 mg adult dose, with median pediatric/adult ratios of 0.93 and 0.91 respectively 2
  • No dose adjustments are needed based on age or weight within this pediatric range, as pharmacokinetic modeling demonstrated no relationship between bilastine exposure and these variables 1, 3

Adolescents and Children ≥12 Years

  • Use the adult dose of 20 mg once daily 4, 5
  • This is the standard approved dose for allergic rhinoconjunctivitis and chronic urticaria in this age group 5

Children <2 Years

  • Bilastine is not recommended for children under 2 years of age, as safety and efficacy data are lacking in this population 4, 1

Critical Administration Requirements

Bilastine must be taken on an empty stomach to ensure proper absorption 4, 5:

  • Administer at least 1 hour before meals 4
  • Wait at least 2 hours after meals before administration 4
  • Avoid concurrent intake with food or fruit juice, as these significantly slow absorption and reduce bioavailability 4, 5

Safety Profile

The safety profile of bilastine 10 mg in children aged 2-11 years is comparable to placebo 2, 3:

  • Treatment-emergent adverse events occurred in only 21.6% of children aged 2-5 years, with none being severe 3
  • No significant difference in adverse event incidence between bilastine and placebo in children aged 6-11 years 2
  • Headache is the most commonly reported adverse effect across all age groups 5
  • No cardiotoxic effects or sedation at therapeutic doses 5

Pharmacokinetic Considerations

  • Peak plasma concentrations occur approximately 1 hour after administration (Cmax ~635 ng/mL in young children) 3
  • Elimination half-life is 14 hours, supporting once-daily dosing 5
  • Bilastine is minimally metabolized and eliminated primarily through kidneys and feces 5
  • No interaction with cytochrome P450 enzymes 5

Common Pitfalls to Avoid

  • Do not administer with meals or fruit juice, as this is the most critical error that compromises drug absorption and therapeutic efficacy 4, 5
  • Do not use in children under 2 years, as there are insufficient data to support safety and appropriate dosing in this age group 4, 1
  • Do not adjust dose based on weight or age within the 2 to <12 year range, as population pharmacokinetic modeling confirmed age-independent kinetics 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.